Peng Zhang's profile

Peng Zhang

Principal Investigator

Northwestern University

I'm working on

6 months ago

Targeting myeloid cells to overcome tumor immunosuppression

About

Tumor-associated myeloid cells (TAMCs) represent a key driver of immunosuppression in many types of cancers. We have engineered innovative therapeutics for effective in vivo targeting and modulation of TAMCs to impair their immunosuppressive activity and/or remodel themto tumor-eradicating cells.

Partnering listings

Learn more

Northwestern University

RNA therapeutic for targeted SPP1 inhibition in tumor-associated myeloid cells

A novel RNA therapeutic utilizing lipid nanoparticles for precision inhibition of SPP1 in tumor-associated myeloid cells, aiming to reprogram these cells and boost anti-tumor immunity by enhancing T cell infiltration and...

TechnologyIn developmentUniversity

Peng Zhang

Principal Investigator

Northwestern University

Work experience

Northwestern University

Principal Investigator

2020 - Present

University of Pittsburgh

PhD, Pharmaceutical Sciences

2010 - 2015

Top industry applications